Indeed, CD204 showed high correlation with immune checkpoints, especially TIM‐3 and PD‐1, suggesting the possible synergy of CD204+ TAMs and immune checkpoint regulators in inhibiting the function of T cells in glioma. The gene discussed is PDCD1; the disease is central nervous system cancer.